Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Vitamin D metabolites are associated with clinical and MRI outcomes in multiple sclerosis patients.

Weinstock-Guttman B, Zivadinov R, Qu J, Cookfair D, Duan X, Bang E, Bergsland N, Hussein S, Cherneva M, Willis L, Heininen-Brown M, Ramanathan M.

J Neurol Neurosurg Psychiatry. 2011 Feb;82(2):189-95. doi: 10.1136/jnnp.2010.227942. Epub 2010 Nov 3.

PMID:
21047880
2.

Interdependence and contributions of sun exposure and vitamin D to MRI measures in multiple sclerosis.

Zivadinov R, Treu CN, Weinstock-Guttman B, Turner C, Bergsland N, O'Connor K, Dwyer MG, Carl E, Ramasamy DP, Qu J, Ramanathan M.

J Neurol Neurosurg Psychiatry. 2013 Oct;84(10):1075-81. doi: 10.1136/jnnp-2012-304661. Epub 2013 Feb 5.

PMID:
23385850
3.

Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis.

Smolders J, Menheere P, Kessels A, Damoiseaux J, Hupperts R.

Mult Scler. 2008 Nov;14(9):1220-4. doi: 10.1177/1352458508094399. Epub 2008 Jul 24.

PMID:
18653736
4.

Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia.

van der Mei IA, Ponsonby AL, Dwyer T, Blizzard L, Taylor BV, Kilpatrick T, Butzkueven H, McMichael AJ.

J Neurol. 2007 May;254(5):581-90. Epub 2007 Apr 11.

PMID:
17426912
5.

Association study on two vitamin D receptor gene polymorphisms and vitamin D metabolites in multiple sclerosis.

Smolders J, Damoiseaux J, Menheere P, Tervaert JW, Hupperts R.

Ann N Y Acad Sci. 2009 Sep;1173:515-20. doi: 10.1111/j.1749-6632.2009.04656.x.

PMID:
19758194
6.

[Vitamin D and multiple sclerosis. A prospective survey of patients of Poitou-Charentes area].

Neau JP, Artaud-Uriot MS, Lhomme V, Bounaud JY, Lebras F, Boissonnot L, Moinot N, Ciron J, Larrieu D, Mathis S, Godeneche G, Ingrand P.

Rev Neurol (Paris). 2011 Apr;167(4):317-23. doi: 10.1016/j.neurol.2010.10.002. Epub 2010 Dec 24. French.

PMID:
21186037
7.

Vitamin D metabolites in diabetic patients: decreased serum concentration of 24,25-dihydroxyvitamin D.

Christiansen C, Christensen MS, McNair P, Nielsen B, Madsbad S.

Scand J Clin Lab Invest. 1982 Oct;42(6):487-91.

PMID:
6760373
8.

Fok-I vitamin D receptor gene polymorphism (rs10735810) and vitamin D metabolism in multiple sclerosis.

Smolders J, Damoiseaux J, Menheere P, Tervaert JW, Hupperts R.

J Neuroimmunol. 2009 Feb 15;207(1-2):117-21. doi: 10.1016/j.jneuroim.2008.12.011.

PMID:
19178954
9.

In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.

Agosta F, Absinta M, Sormani MP, Ghezzi A, Bertolotto A, Montanari E, Comi G, Filippi M.

Brain. 2007 Aug;130(Pt 8):2211-9. Epub 2007 May 29.

PMID:
17535835
10.

Serial MRI in multiple sclerosis: a prospective pilot study of lesion load, whole brain volume and thalamic atrophy.

Taylor I, Butzkueven H, Litewka L, MacGregor LR, Szoeke C, Cook M, Mitchell P, Kilpatrick TJ, Tubridy N.

J Clin Neurosci. 2004 Feb;11(2):153-8.

PMID:
14732374
11.

Vitamin D and multiple health outcomes in the Harvard cohorts.

Wei MY, Giovannucci EL.

Mol Nutr Food Res. 2010 Aug;54(8):1114-26. doi: 10.1002/mnfr.200900574. Review.

PMID:
20486209
12.

Peripheral blood regulatory T cell measurements correlate with serum vitamin D levels in patients with multiple sclerosis.

Royal W 3rd, Mia Y, Li H, Naunton K.

J Neuroimmunol. 2009 Aug 18;213(1-2):135-41. doi: 10.1016/j.jneuroim.2009.05.012. Epub 2009 Jun 17.

PMID:
19539379
13.

Safety of vitamin D3 in adults with multiple sclerosis.

Kimball SM, Ursell MR, O'Connor P, Vieth R.

Am J Clin Nutr. 2007 Sep;86(3):645-51.

14.

Vitamin D metabolites--relation to age, menopause and endometriosis.

Hartwell D, Rødbro P, Jensen SB, Thomsen K, Christiansen C.

Scand J Clin Lab Invest. 1990 Apr;50(2):115-21.

PMID:
2339276
15.

The estimation of vitamin D and some metabolites in human plasma by mass fragmentography.

Seamark DA, Trafford DJ, Makin HL.

Clin Chim Acta. 1980 Sep 8;106(1):51-62.

PMID:
6250743
16.

Quantitative diffusion weighted imaging measures in patients with multiple sclerosis.

Tavazzi E, Dwyer MG, Weinstock-Guttman B, Lema J, Bastianello S, Bergamaschi R, Cosi V, Benedict RH, Munschauer FE 3rd, Zivadinov R.

Neuroimage. 2007 Jul 1;36(3):746-54. Epub 2007 Apr 10.

PMID:
17498974
17.

Osteopenia with normal vitamin D metabolites after small-bowel resection for Crohn's disease.

Hessov I, Mosekilde L, Melsen F, Fasth S, Hultén L, Lund B, Lund B, Sørensen OH.

Scand J Gastroenterol. 1984 Jul;19(5):691-6.

PMID:
6332369
18.

One-dimensional-ratio measures of atrophy progression in multiple sclerosis as evaluated by longitudinal magnetic resonance imaging.

Martola J, Stawiarz L, Fredrikson S, Hillert J, Bergström J, Flodmark O, Aspelin P, Wiberg MK.

Acta Radiol. 2009 Oct;50(8):924-32. doi: 10.1080/02841850903062732.

PMID:
19639474
19.

HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.

Zivadinov R, Uxa L, Bratina A, Bosco A, Srinivasaraghavan B, Minagar A, Ukmar M, Benedetto Sy, Zorzon M.

Int Rev Neurobiol. 2007;79:521-35.

PMID:
17531857
20.

Feto-maternal relationships between vitamin D metabolites in Israeli Bedouins and Jews.

Shany S, Biale Y, Zuili I, Yankowitz N, Berry JL, Mawer EB.

Am J Clin Nutr. 1984 Dec;40(6):1290-4.

PMID:
6334437

Supplemental Content

Support Center